An observational study in Chronic Pain and Limb Fracture, sponsored by University of Nottingham. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2025-11-19.
Sponsored by University of Nottingham · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 116 studies in Chronic Pain with a site in United Kingdom — 19 open to participants now, 21 under way, none of them phase 3. Chronic Pain · United Kingdom.
Among the 116 studies in Chronic Pain with a site in United Kingdom, this one is the 13th largest by planned enrollment of the 47 observational ones that give a count, is one of 4 that started in 2025, is one of 47 observational ones, reaches primary completion later than 14 of the 20 other live ones, and was the 110th registered.
3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.
Browse Chronic Pain studies →19 of the 116 studies in Chronic Pain with a site in United Kingdom are open now. Recruiting first, the newest first:
Cambridge University Hospitals NHS Foundation Trust · Sites in United Kingdom
Ages 18+
University of Oxford · Sites in United Kingdom
Ages 18+
VM Therapeutics LLC · Sites in United Kingdom
Ages 18–80
University of Nottingham · Sites in United Kingdom
Ages 40+ · Healthy volunteers
NHS Greater Glasgow and Clyde · Sites in United Kingdom
Ages 18–75
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.
This study: 16 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
116 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 5 · Phase 3 9 · Phase 4 2
First in 2001; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 450 is above the median of 120 across 755 observational studies indexed under Chronic Pain.
Median enrollment 60 across the 69 interventional studies, 132 across the 47 observational. Of the 73 that completed or were terminated, 17 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
35 of 116 have an industry lead sponsor. The 10 most frequent:
University of Nottingham is the lead sponsor of 465 studies on the registry; 80 are open to participants now.
University of Nottingham has 8 studies filed under Chronic Pain — fewer than ten, so there is no comparison to draw.
5 of the studies in Chronic Pain with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07096661Bournemouth UniversityPain Science Education for Labour and Postpartum Pain | 2026-12-01 |
| NCT06240299NHS Greater Glasgow and ClydeNeurofeedback for Nociplastic Pain in Rheumatoid Arthritis (NECTAR) | 2027-01-29 |
| NCT07698041Katherine FinlayRUTISS-Diary and RUTISS-65 Study | 2027-06-30 |
| NCT07072468VM Therapeutics LLCAnalgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN) | 2027-06-30 |
| NCT07237152University of NottinghamChronic Pain Predictors in Major Trauma | 2027-10 |
Add all 5 to your calendar (.ics) → With an account.
Among the 116 studies in Chronic Pain with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to learn about who is at risk of developing chronic pain in a major trauma population with at least one limb fracture.
The main question it aims to answer is: which risk factors predict which patients will experience chronic pain following traumatic limb injury.
Participants will answer a baseline questionnaire and two outcome questionnaires about their pain at 3 and 6 months after their injury.
Adult major trauma patients with a minimum of one limb fracture treated at the East Midlands Major Trauma Centre based at Nottingham University Hospitals NHS Trust
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Aged ≥ 16 Polytrauma patient (multiple injuries affecting multiple body regions or organ systems) Admitted to a UK Major Trauma Centre Minimum of 1 radiologically confirmed traumatic limb fracture Have capacity to provide to participate in the study Have sufficient proficiency in English to provide the required data or be willing to use an approved interpreting service for data collection Recruited within 4 weeks of injury
Exclusion Criteria:
No traumatic limb fracture Patients with a primary or treatment amputation in relation to their limb injury Pathological limb fractures Prisoners No fixed abode
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Presence of chronic pain
Assessed using a 11-point numerical rating scale from 0 (no pain) - 10 (worst possible pain).
Time frame: Reported at baseline, 3 and 6 months post-injury
Severity of chronic pain
Assessed using a 11-point numerical rating scale from 0 (no pain) - 10 (worst possible pain).
Time frame: Reported at baseline, 3 and 6 months post-injury
Pain impact
Assessed using the six-item pain interference index
Time frame: Reported at baseline, 3 and 6 months post-injury
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Dec 2025; primary completion for Oct 2027, 22 months later.
Of 337 non-industry observational studies under Chronic Pain, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 56. This study's planned 22 months is close to that.
Counting every sponsor, half of 363 studies reached it within 24 months; a quarter within 12 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.